Paper Details

  1. Home
  2. Paper Details

Assessment of the Cytoprotective Effects of High-Dose Valproic Acid Compared to a Clinically Used Lower Dose.

Author: AlamHasan B, BhattiUmar F, BiesterveldBen E, KempMichael, LiYongqing, LiuBaoling, RemmerHenriette, RussoRachel, TagettRebecca, WakamGlenn, WilliamsAaron M

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, U.S. Gov't, Non-P.H.S.Research funding provided by US government agencies other than the Public Health Service.

Overview

This study investigated the proteomic changes induced by a single high-dose of valproic acid (VPA) compared to the FDA-approved dose in healthy humans and an injured patient. The researchers found that a high dose of VPA induced changes in protein levels that may be associated with cytoprotective effects.
Paper Details　
Original Abstract of the Article :
Valproic acid (VPA) treatment improves survival in animal models of injuries on doses higher than those allowed by Food and Drug Administration (FDA). We investigated the proteomic alterations induced by a single high-dose (140mg/kg) of VPA (VPA140) compared to the FDA-approved dose of 30mg/kg (VPA3...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jss.2021.03.025

データ提供：米国国立医学図書館（NLM）

Valproic Acid: A Desert Oasis of Cytoprotection

Valproic acid (VPA), a commonly used antiepileptic drug, is like a versatile desert plant, offering a range of therapeutic benefits. This study investigates the potential cytoprotective effects of high-dose VPA compared to the standard clinical dose. It's like exploring the different properties of this desert plant, seeking to understand how its impact varies depending on the dosage.

High-Dose VPA: A New Oasis of Protection?

The researchers found that high-dose VPA induced specific changes in the proteins and genes of study participants, suggesting a potential protective effect. It's like discovering a hidden spring in the desert, providing a surge of beneficial compounds. While this research is preliminary, it suggests that high-dose VPA may offer additional benefits beyond those seen with standard doses. However, further research is needed to confirm these findings and determine the optimal dosage for maximizing cytoprotective effects and minimizing potential risks.

Navigating the Desert of Drug Dosage

This research highlights the importance of considering the potential benefits and risks of different drug dosages. It's like a desert traveler, carefully choosing the right path to avoid treacherous terrain and maximize their chances of survival. It's essential to consult with a healthcare professional to determine the appropriate dosage for your individual needs and health conditions.

Dr.Camel's Conclusion

This study delves into the potential cytoprotective effects of high-dose valproic acid. While more research is needed to fully understand its mechanisms and safety, this research suggests that high-dose VPA may offer additional benefits beyond those seen with standard doses. It's crucial to approach drug dosage with careful consideration, ensuring that the benefits outweigh the risks and that the dosage is tailored to individual needs. Remember, the journey through the desert of medical treatment is best navigated with the guidance of experienced healthcare professionals.

Date :
  1. Date Completed 2021-09-27
  2. Date Revised 2021-09-27
Further Info :

Pubmed ID

33991999

DOI: Digital Object Identifier

10.1016/j.jss.2021.03.025

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.